Rodey Law Firm
 
 
 
 


Representative Matters: Drug and Medical Device Liability


Rodey has represented Wyeth in over eighty separate fenfluramine and dexfenfluramine cases totaling nearly 500 plaintiffs. Rodey has assisted in trying two cases to verdict and helped reach the first phen-fen defense verdict in the country.

Rodey has represented Wyeth in seven PPA cases and has helped secure dismissals with prejudice in three of these cases to date.

Rodey has represented Pfizer in a putative New Mexico consumer fraud class action related to sales of Neurontin and helped defeat class certification in that case.

Rodey represented Pfizer and Pharmacia & Upjohn in a wrongful pregnancy case related to the Plaintiff’s use of Depo-Provera, and helped secure a dismissal with prejudice in that case.

Rodey represented Eli Lilly in a Zyprexa case and helped secure a dismissal.

Rodey represented Eli Lilly in a putative class action related to use of human synthetic insulin, and helped secure a dismissal of that case.

Rodey represented Sankyo Pharma in 12 Rezulin cases.


 
 
 
 
 
 
 
 
 


Copyright © 2003-2005 Rodey, Dickason, Sloan Akin, & Robb, PA

 
 website design by Teknea Design